Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0066
-0.0004 (-5.71%)
May 26, 2026, 3:10 PM EST
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $874.7 thousand as of May 27, 2026. Its market cap has decreased by -9.22% in one year.
Market Cap
874.70K
Enterprise Value
56.63M
Revenue
20.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 874.70K, a decrease of -99.59%. That is a compound annual growth rate of -48.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 874.70K | -27.32% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyra Therapeutics | 1.24M |
| Protagenic Therapeutics | 988.37K |
| CERo Therapeutics Holdings | 969.90K |
| Halberd | 896.76K |
| Agentix | 841.41K |
| Avenue Therapeutics | 793.72K |
| SQZ Biotechnologies Company | 707.79K |
| Emmaus Life Sciences | 701.88K |